{"id":"W2214942476","doi":"10.1634/theoncologist.2015-0295","title":"S0502: A SWOG Phase III Randomized Study of Imatinib, With or Without Bevacizumab, in Patients With Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors","year":2015,"lang":"en","type":"article","venue":"The Oncologist","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Medicine; Bevacizumab; Imatinib; Oncology; Internal medicine; Stromal cell; Phases of clinical research; Imatinib mesylate; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002907506,0.001546927,0.001851859,0.0005828206,0.0003643781,0.001459935,0.001064315,0.001940197,0.00616174],"category_scores_gemma":[0.0015462,0.0005048051,0.002018863,0.0005908509,0.001361312,0.001443843,0.0004817909,0.003018755,0.001044719],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008204163,"about_ca_system_score_gemma":0.002036478,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001086849,"about_ca_topic_score_gemma":0.004968575,"domain_scores_codex":[0.9991191,0.0005966863,0.00005003073,0.0000846629,0.0000613611,0.00008813949],"domain_scores_gemma":[0.9990658,0.0002117363,0.0001514833,0.00004147579,0.00005727366,0.0004721998],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9241372,0.01800279,0.002428472,0.001000709,0.001459358,0.000167677,0.0001626589,0.000926105,0.007665696,0.0004982843,0.004186655,0.03936438],"study_design_scores_gemma":[0.9130489,0.08275549,0.001831554,0.00003442543,0.0002811047,0.00005841633,0.00003100912,0.0004116695,0.0003283765,0.0001299628,0.001074029,0.0000151026],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9790193,0.004850392,0.0009653711,0.003217956,0.0008003689,0.005139215,0.001798201,0.0002094318,0.003999752],"genre_scores_gemma":[0.9760113,0.002932053,0.003280283,0.004725672,0.000581965,0.004721077,0.002748952,0.00003237787,0.004966414],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00616174,"threshold_uncertainty_score":0.02061313,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06706704764157113,"score_gpt":0.3680813062434201,"score_spread":0.3010142586018489,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}